Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.398
+0.017 (4.57%)
At close: Nov 4, 2024, 4:00 PM
0.386
-0.012 (-2.94%)
After-hours: Nov 4, 2024, 7:30 PM EST
Aptose Biosciences Stock Forecast
APTO's stock price has decreased by -86.7% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Aptose Biosciences stock have an average target of 9.00, with a low estimate of 5.00 and a high estimate of 18. The average target predicts an increase of 2,162.44% from the current stock price of 0.40.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 14, 2024.
Analyst Ratings
The average analyst rating for APTO stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,659.68% | Jun 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +1,408.30% | May 16, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $5 | Buy | Maintains | $5 | +1,156.91% | Apr 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +5,681.80% | Mar 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $5 | Buy | Maintains | $12 → $5 | +1,156.91% | Feb 1, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.41
from -7.58
EPS Next Year
-2.23
from -4.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -4.54 | -2.30 | -1.84 |
| Avg | -4.41 | -2.23 | -1.79 |
| Low | -4.23 | -2.15 | -1.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.